4th Nov 2014 10:32
LONDON (Alliance News) - Molecular diagnostics company Premaitha Health PLC on Tuesday said it is on track with the development of its IONA non-invasive pre-natal screening test.
The company said the development and launch preparations for the product are on schedule and said the test has performed well in verification studies.
Premaitha said it has seen positive interest in the product in the UK, Europe, Asia and Australasia.
Premaitha shares were up 1.3% to 19.75 pence on Tuesday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Premaitha Health